Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Genest

Showing results (201-210 of 214) with videos related to

Pageof 22
Sort By:
The Canadian Journal of Cardiology|August 11, 2018
Simplified Canadian Definition for Familial HypercholesterolemiaIsabelle Ruel, Diane Brisson, Sumayah Aljenedil, et al.
The Canadian Journal of Cardiology|March 30, 2021
2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in AdultsGlen J Pearson, George Thanassoulis, Todd J Anderson, et al.
Communications Biology|February 16, 2022
Macrophage Jak2 deficiency accelerates atherosclerosis through defects in cholesterol effluxIdit Dotan, Jiaqi Yang, Jiro Ikeda, et al.
Atherosclerosis|June 2, 2026
Homozygous familial hypercholesterolemia (HoFH) in CanadaZobaida Al-Baldawi, Armen Erzingatzian, Isabelle Ruel, et al.
JACC. Advances|January 24, 2026
Aortic Stenosis in Homozygous Familial Hypercholesterolemia: The Canadian HoFH RegistryArmen Erzingatzian, Zobaida Al-Baldawi, Isabelle Ruel, et al.
The Canadian Journal of Cardiology|December 12, 2018
Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018Liam R Brunham, Isabelle Ruel, Sumayah Aljenedil, et al.
The Lancet. Diabetes & Endocrinology|June 2, 2016
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia PanelRaul D Santos, Samuel S Gidding, Robert A Hegele, et al.
The New England Journal of Medicine|August 29, 2017
Antiinflammatory Therapy with Canakinumab for Atherosclerotic DiseasePaul M Ridker, Brendan M Everett, Tom Thuren, et al.
The Canadian Journal of Cardiology|April 5, 2011
Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group, Lawrence A Leiter, David H Fitchett, et al.
The Canadian Journal of Cardiology|April 5, 2011
Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary), Lawrence A Leiter, David H Fitchett, et al.
Pageof 22

Showing results (201-210 of 214) with videos related to

Sort By:
Pageof 22
The Canadian Journal of Cardiology|August 11, 2018
Simplified Canadian Definition for Familial HypercholesterolemiaIsabelle Ruel, Diane Brisson, Sumayah Aljenedil, et al.
The Canadian Journal of Cardiology|March 30, 2021
2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in AdultsGlen J Pearson, George Thanassoulis, Todd J Anderson, et al.
Communications Biology|February 16, 2022
Macrophage Jak2 deficiency accelerates atherosclerosis through defects in cholesterol effluxIdit Dotan, Jiaqi Yang, Jiro Ikeda, et al.
Atherosclerosis|June 2, 2026
Homozygous familial hypercholesterolemia (HoFH) in CanadaZobaida Al-Baldawi, Armen Erzingatzian, Isabelle Ruel, et al.
JACC. Advances|January 24, 2026
Aortic Stenosis in Homozygous Familial Hypercholesterolemia: The Canadian HoFH RegistryArmen Erzingatzian, Zobaida Al-Baldawi, Isabelle Ruel, et al.
The Canadian Journal of Cardiology|December 12, 2018
Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018Liam R Brunham, Isabelle Ruel, Sumayah Aljenedil, et al.
The Lancet. Diabetes & Endocrinology|June 2, 2016
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia PanelRaul D Santos, Samuel S Gidding, Robert A Hegele, et al.
The New England Journal of Medicine|August 29, 2017
Antiinflammatory Therapy with Canakinumab for Atherosclerotic DiseasePaul M Ridker, Brendan M Everett, Tom Thuren, et al.
The Canadian Journal of Cardiology|April 5, 2011
Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group, Lawrence A Leiter, David H Fitchett, et al.
The Canadian Journal of Cardiology|April 5, 2011
Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary), Lawrence A Leiter, David H Fitchett, et al.
Pageof 22